To better plan the Committees' workload, ECHA has established specific windows for submitting applications for authorisation. Uploading your application within these windows ensures the minimum processing time for your application by ECHA and its Committees.

The table below shows the substance names and their corresponding latest submission window (i.e. the last window before the latest application date).

You can benefit from the transitional arrangements of Art. 58(1)(c)(ii) of REACH if you submit your application to ECHA in the latest or in any of the earlier submission windows.

To ensure that the application is processed smoothly, ECHA recommends that you submit the application in one of the windows before the latest submission window. See Q&A 571 and 572 for more details.

• Previous submission windows

Submission window - (corresponding latest application date)	Substances
2020
7 - 21 February	Submission window available for all substances
7 - 21 May	Submission window available for all substances
7 - 21 August	Submission window available for all substances
6 - 20 November	Submission window available for all substances
2021
8 - 22 February	Submission window available for all substances
7 - 21 May	Submission window available for all substances
6 - 20 August	Submission window available for all substances and latest submission window for: 1,2-Benzenedicarboxylic acid, dihexyl ester, branched and linear (EC 271-093-5) Dihexyl phthalate (EC 201-559-5) 1,2-benzenedicarboxylic acid, di-C6-10-alkyl esters; 1,2-benzenedicarboxylic acid, mixed decyl and hexyl and octyl diesters with ≥ 0,3 % of dihexyl phthalate (EC No 201-559-5) (EC 271-094-0; 272-013-1)
8 - 22 November	Submission window available for all substances and latest submission window for: Trixylyl phosphate (EC 246-677-8) Sodium perborate; perboric acid, sodium salt (EC 239-172-9; 234-390-0) Sodium peroxometaborate (EC 231-556-4)
2022
7 - 21 February	Submission window available for all substances and latest submission window for: 5-sec-butyl-2-(2,4-dimethylcyclohex-3-en-1- yl)-5-methyl-1,3-dioxane [1], 5-sec-butyl-2- (4,6-dimethylcyclohex-3-en-1-yl)-5-methyl- 1,3-dioxane [2] [covering any of the individual stereoisomers of [1] and [2] or any combination thereof]
6 - 20 May	Submission window available for all substances and latest submission window for: 2-(2H-benzotriazol-2-yl)-4,6-ditertpentylphenol (UV-328) (EC 247-384-8) 2,4-di-tert-butyl-6-(5-chlorobenzotriazol-2- yl)phenol (UV-327) (EC 223-383-8) 2-(2H-benzotriazol-2-yl)-4-(tert-butyl)-6- (sec-butyl)phenol (UV-350) (EC 253-037-1) 2-benzotriazol-2-yl-4,6-di-tert-butylphenol (UV-320) (EC 223-346-6)
8 - 22 August	Submission window available for all substances
7 - 21 November	Submission window available for all substances
2023
7 - 21 February	Submission window available for all substances
8 - 22 May	Submission window available for all substances
7 - 21 August	Submission window available for all substances
6 - 20 November	Submission window available for all substances

 

Note: These submission windows may be revised if the meetings of RAC and SEAC are held on different dates to the ones currently planned.